TGFBR2 and cervical squamous intraepithelial neoplasia: For patients who are premenopausal, are older, have CINII+ results from TCT, have high parity, have high expression of TGFBR2, CSKN1A1, PRKCI, and CTBP2, and exhibit low expression of FOXO1, more attention should be paid to CIN progression.